1
|
Laurin A, Capelle N, Bukowski N, Le Page A, Gendre I, Sauvaget A, Bulteau S. [Ketamine and lorazepam combination as an alternative to electroconvulsive therapy for catatonia in late-life depression: A case report]. Encephale 2023; 49:535-536. [PMID: 36907667 DOI: 10.1016/j.encep.2023.01.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/13/2021] [Revised: 12/16/2022] [Accepted: 01/10/2023] [Indexed: 03/12/2023]
Affiliation(s)
- A Laurin
- Neuromodulation and Liaison Psychiatry Unit, CHU de Nantes, 44000 Nantes, France.
| | - N Capelle
- Neuromodulation and Liaison Psychiatry Unit, CHU de Nantes, 44000 Nantes, France
| | - N Bukowski
- Neuromodulation and Liaison Psychiatry Unit, CHU de Nantes, 44000 Nantes, France
| | - A Le Page
- Neuromodulation and Liaison Psychiatry Unit, CHU de Nantes, 44000 Nantes, France
| | - I Gendre
- Neuromodulation and Liaison Psychiatry Unit, CHU de Nantes, 44000 Nantes, France
| | - A Sauvaget
- Neuromodulation and Liaison Psychiatry Unit, CHU de Nantes, 44000 Nantes, France
| | - S Bulteau
- Neuromodulation and Liaison Psychiatry Unit, CHU de Nantes, 44000 Nantes, France
| |
Collapse
|
2
|
Sauvaget A, Guitteny M, Bukowski N, Duffieux V, Mezouari A, Brisson A, Raveneau C, Gohier B, Bulteau S. [Treatments for depression in consultation-liaison psychiatry: From theory to practice]. Rev Med Interne 2021; 42:694-706. [PMID: 34256970 DOI: 10.1016/j.revmed.2021.06.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2020] [Revised: 06/10/2021] [Accepted: 06/21/2021] [Indexed: 10/20/2022]
Abstract
Treatments for depression include an adapted lifestyle, physical activity, psychotherapies, antidepressant and mood stabilizing drugs, neuromodulation, chronotherapy, spa treatments. Drug treatments used for major depressive episode are antidepressants and mood stabilizers. For a mild episode, psychotherapy is indicated. It should be combined with an antidepressant (serotonin reuptake inhibitor) for moderate and severe episodes. Suicide risk assessment is essential throughout the depressive episode. It is recommended to monitor at the start of antidepressant treatment for suicidal behavior, a change in mood suggesting an underlying bipolar disorder. The effectiveness of the treatment is evaluated after 4 to 8 weeks. The total duration of antidepressant treatment for an EDC is between 6 months and 1 year after remission, in order to prevent relapses. The use of liaison psychiatry, a real healthcare system within the general hospital, is strongly recommended for better screening and treatment of depression, thus reducing the length of hospital stays, improving the prognosis of depression. The aim of this article is to provide clinicians with a summary of validated data on the efficacy/tolerance of treatment for depression, and to suggest practical action to be taken on the main daily clinical situations: treating comorbid conditions, taking into account interactions drugs, manage the serotonin syndrome, lead to withdrawal from antidepressants, manage treatment in the elderly.
Collapse
Affiliation(s)
- A Sauvaget
- Nantes Université, CHU Nantes, Movement, Interactions, Performance (MIP), EA 4334,University of Nantes, Nantes, France.
| | - M Guitteny
- CHU Nantes, Department of Addictology and Liaison Psychiatry, Nantes, France
| | - N Bukowski
- CHU Nantes, Department of Addictology and Liaison Psychiatry, Nantes, France
| | - V Duffieux
- CHU Nantes, Department of Addictology and Liaison Psychiatry, Nantes, France; Centre Hospitalier Loire Vendée Océan (CHLVO), Psychiatrie de liaison, boulevard Guérin, 85300 Challans, France
| | - A Mezouari
- Centre Hospitalier Loire Vendée Océan (CHLVO), Psychiatrie de liaison, boulevard Guérin, 85300 Challans, France
| | - A Brisson
- CHU Nantes, Department of Addictology and Liaison Psychiatry, Nantes, France
| | - C Raveneau
- UPRES, EA 4638, département de psychiatrie et d'addictologie, université d'Angers, CHU d'Angers, Angers, France
| | - B Gohier
- UPRES, EA 4638, département de psychiatrie et d'addictologie, université d'Angers, CHU d'Angers, Angers, France
| | - S Bulteau
- CHU Nantes, Department of Addictology and Liaison Psychiatry, Nantes, France; Inserm-U1246 SPHERE University of Nantes and University of Tours, Nantes, France
| |
Collapse
|
3
|
Sauvaget A, Dumont R, Bukowski N, Bonnot O, Auffret R, Poulet E, Szekely D, Quiles C, Yrondi A, Plaze M, de Carvalho W, Amad A, Bulteau S. [Recommendations for a gradual and controlled resumption of electroconvulsive therapy in France during the period of lifting of the containment and of the COVID-19 pandemic linked to SARS-CoV-2]. Encephale 2020; 46:S119-S122. [PMID: 32507557 PMCID: PMC7271849 DOI: 10.1016/j.encep.2020.05.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/08/2020] [Accepted: 05/17/2020] [Indexed: 11/18/2022]
Abstract
La pandémie du COVID-19 a des conséquences majeures sur l’organisation des soins. En France et dans le monde, les centres pratiquant l’électroconvulsivothérapie (ECT) ont vu leur activité diminuer, voire s’arrêter, pour de diverses raisons. Dans ce contexte, le maintien ou la reprise de cette activité thérapeutique essentielle pour de nombreux patients souffrant de troubles psychiatriques nécessite des adaptations matérielles, humaines et logistiques qu’il convient d’encadrer. L’objectif de ce travail collectif et national est de proposer des recommandations simples et applicables immédiatement par tout établissement de santé, public ou privé, pratiquant les ECT. Elles sont issues d’un retour d’expériences pluriprofessionnelles et interétablissements. Déclinées en trois étapes, ces recommandations sont accompagnées d’une fiche pratique qui décrit, de façon précise, les conditions nécessaires et préalables à toute reprise d’activité ECT.
Collapse
Affiliation(s)
- A Sauvaget
- French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Nantes Université, CHU Nantes, Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes, France.
| | - R Dumont
- CHU de Nantes, Department of Anesthesiology and Critical Care Medicine, Hôtel-Dieu-PTMC, Nantes, France
| | - N Bukowski
- CHU Nantes, Department of Addictology and Psychiatry, Nantes, France
| | - O Bonnot
- Child and Adolescent Psychiatry Department, CHU and University of Nantes, Nantes, France
| | - R Auffret
- CHU Nantes, Department of Addictology and Psychiatry, Nantes, France
| | - E Poulet
- French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Centre hospitalier Le Vinatier, Bron, France; Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 69000 Lyon, France; University Lyon 1, 69000 Villeurbanne, France; Department of Emergency Psychiatry, hospices civils de Lyon, University Hospital Edouard-Herriot, Lyon, France
| | - D Szekely
- French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Department of psychiatry, centre hospitalier Princesse-Grace, 98000 Monaco, France
| | - C Quiles
- Centre hospitalier Charles-Perrens, 33000 Bordeaux, France
| | - A Yrondi
- French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Service de psychiatrie et de psychologie médicale, centre expert dépression résistante fondamental, CHU de Toulouse, Toulouse, France; Inserm, UPS, ToNIC Toulouse NeuroImaging Center, hôpital Purpan, université de Toulouse, Toulouse, France
| | - M Plaze
- French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; Université de Paris, 75005 Paris, France; Service hospitalo-universitaire, GHU de Paris psychiatrie & neurosciences, 75014 Paris, France
| | - W de Carvalho
- Pôle ECT - groupe SINOUÉ, clinique BELLEVUE, 92190 Meudon, France
| | - A Amad
- Inserm, U1172 - LilNCog - Lille Neuroscience & Cognition, CHU de Lille, université de Lille, 59000 Lille, France
| | - S Bulteau
- French Society for Biological Psychiatry and Neuropsychopharmacology, STEP Section (Stimulation transcrânienne en psychiatrie), Saint-Germain-en-Laye, France; CHU Nantes, Department of Addictology and Psychiatry, Nantes, France; Inserm-U1246 SPHERE University of Nantes and University of Tours, Nantes, France
| |
Collapse
|